Mariner Wealth Advisors (NYC)’s iShares Biotechnology ETF IBB Stock Holding History

Mariner Wealth Advisors (NYC)’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$21K	Buy	+180	New	+$19.9K	0.01%	269

Other funds holding IBB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BFA

Beaumont Financial Advisors Needham, Massachusetts $1.57B AUM 25.77% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Mariner Wealth Advisors (NYC)'s IBB Position: Q1 2015 in Review

Mariner Wealth Advisors (NYC) opened a new position in iShares Biotechnology ETF (IBB) in Q1 2015: 180 shares worth $21K. The stake represents 0.01% of the portfolio and ranks #269 among its holdings.

400 funds tracked by Wall St. Rank hold IBB as of Q1 2015.

Mariner Wealth Advisors (NYC) held 180 shares of iShares Biotechnology ETF worth $21K as of Q1 2015.
iShares Biotechnology ETF was a new Mariner Wealth Advisors (NYC) position in Q1 2015.
iShares Biotechnology ETF made up 0.01% of Mariner Wealth Advisors (NYC)'s portfolio in Q1 2015, its #269 holding.
400 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2015.

Based on Mariner Wealth Advisors (NYC)'s 13F filing for Q1 2015, filed 14 May 2015.